Immediate Impact

55 standout
Sub-graph 1 of 22

Citing Papers

Efficacy, Immunogenicity, and Safety of the Bivalent Respiratory Syncytial Virus (RSV) Prefusion F Vaccine in Older Adults Over 2 RSV Seasons
2025 Standout
A truncated pre-F protein mRNA vaccine elicits an enhanced immune response and protection against respiratory syncytial virus
2025 Standout
2 intermediate papers

Works of Vivían Luchsinger being referenced

SP-A1, SP-A2 and SP-D gene polymorphisms in severe acute respiratory syncytial infection in Chilean infants
2011
Impaired Immune Response in Severe Human Lower Tract Respiratory Infection by Respiratory Syncytial Virus
2009

Author Peers

Author Last Decade Papers Cites
Vivían Luchsinger 260 120 55 12 297
K. Kallergi 298 117 74 6 334
Ana Baće 242 137 77 14 292
Frederic W. Bruhn 233 113 76 8 334
Shen-Hao Lai 166 79 34 12 291
Ada Lin 178 47 123 17 325
Alejandro Torres 200 63 34 9 325
Jamie Yuen 287 119 108 12 326
Markku Pulkkinen 167 120 43 7 330
James Inglis 192 123 66 12 295
Matthias Hoffmann 140 17 78 9 309

All Works

Loading papers...

Rankless by CCL
2026